DC Brands International, Inc.: DC Brands' Team Oversees Largest Production Run Yet
DENVER, CO--(Marketwire - May 12, 2009) - Today, DC Brands International, Inc. (
The company's President Richard Pearce said, "The goal is absolutely no mistakes this time. We can't afford them. In the past, we were working through both R&D and manufacturing difficulties that are frustrating, but also they are just a part of the learning process when you are pioneering something new that has never been done before. However, we have documented what can go wrong and drastically upgraded our Q&A procedures to anticipate and mitigate, if not eliminate, any potential problems before they can occur."
Pearce went on to say, "What we do sounds easy enough; just put some pills in the top of a cap at a really high rate of speed. What is so hard? It is far more complicated than that. There is a lot more that goes into producing a one of a kind product like ours. We are proud to be able to say we have overcome all setbacks and not only have our caps patented, but own the IP for the processes as well."
Pearce continues, "Again, a substantial number of significant challenges needed to be overcome and we are very proud to announce that we have overcome those challenges and it is reason for our shareholders to be excited as well as this has happened not a day too soon. Next week, we will begin an aggressive rollout of our fantastic products and we are pleased to be able to announce this news to all of our loyal shareholders. There are pending sales announcements of where that product is going and this should help everyone understand that we have turned a significant corner in R&D and direct sales and are becoming a full blown sales organization."
About DC Brands International:
DC Brands International, a publicly traded company under the ticker symbol (
For more information on DC Brands International, visit their website at [ www.HardNutrition.com ].
Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.